ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $168,000 | -10.2% | 15,800 | +20.6% | 0.04% | +21.9% |
| Q4 2021 | $187,000 | -57.8% | 13,100 | -40.7% | 0.03% | -60.5% |
| Q3 2021 | $443,000 | +84.6% | 22,100 | +102.8% | 0.08% | +84.1% |
| Q2 2021 | $240,000 | -77.2% | 10,900 | -64.8% | 0.04% | -78.7% |
| Q1 2021 | $1,051,000 | – | 30,950 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 7,305,761 | $104,472,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $53,961,000 | 89.75% |
| Gruss & Co., LLC | 426,966 | $6,106,000 | 16.39% |
| SB Management Ltd | 9,817,190 | $140,386,000 | 13.88% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $58,703,000 | 5.51% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $45,346,000 | 4.36% |
| Intellectus Partners, LLC | 1,192,379 | $17,051,000 | 4.35% |
| Founders Fund Growth Management, LLC | 407,017 | $5,820,000 | 3.28% |
| ArchPoint Investors | 461,289 | $6,596,000 | 1.96% |
| Belmont Capital, LLC | 150,000 | $2,145,000 | 1.68% |